Track topics on Twitter Track topics that are important to you
ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the ...
Treatment of inflammatory and autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis and multiple sclerosis.
Substantial advances in multiple sclerosis research have occurred in recent years, from the advent of oral therapies for relapsing-remitting multiple sclerosis1 to the discovery of previously unknown ...
March has been proclaimed Multiple Sclerosis Awareness Month, spotlighting MS awareness, support and resources. Multiple sclerosis (MS) is a chronic disease of the nervous system that affects differen...
The last couple of decades have seen major progress in the treatment of relapsing-remitting multiple sclerosis (RRMS), with a number of drug approvals. In contrast, clinical trials of drug candidates ...
Appropriate treatment of anxiety is of paramount importance in the primary care setting. Family practice providers are in a position to best understand each patient's background, resources and challen...
Drugs Lessen Multiple Sclerosis Damage in MiceIn a mouse study, 2 drugs already on the market activated stem cells and repaired the type of brain damage seen in multiple sclerosis. The finding might ...
New research into the causes of the excessive inflammation that drives multiple sclerosis has identified a faulty 'brake' within immune cells, a brake that should be controlling the inflammation. This...
(University of Virginia Health System) New research into the causes of the excessive inflammation that drives multiple sclerosis has identified a faulty 'brake' within immune cells, a brake that shoul...
Multiple sclerosis is the most common neurological disease in young adults, usually striking between the ages of 20 and 40 years.
Multiple sclerosis is an inflammatory demyelinating disease affecting the central nervous system and considered one of the leading causes of disability in young adults. The precise cause of multiple s...
For many years, cognitive impairment has been established as a well-known symptom of multiple sclerosis. Moreover, we know that it was present even at the beginning of the disease.
Fatigue is one of the most common and disabling symptoms of multiple sclerosis (MS); however, there is no medication that has been approved specifically to treat MS-related fatigue.
There have been no clinical trials for approval of medications for treating multiple sclerosis in patients younger than age 18 years. All treatments are based on personal experience and data from ope...
Memory impairment is frequent in multiple sclerosis (MS), but it is unclear what functional brain changes underlie this cognitive deterioration.